BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS

Marla C. Dubinsky  1     April Naegeli  2     Mingyang Shan  2     Cem Kayhan  2     Catherine Milch  2     Jochen Schmitz  2     Sylvie Bradesi  2     Simon Travis  3    
1 Mount Sinai Hospital, Mount Sinai, New York City, United States
2 Eli Lilly and Company, Indianapolis, United States
3 Oxford University Hospitals, Oxford, United Kingdom

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing